Etubics

16 articles about Etubics

• Etubics Platform Shown To Significantly Increase Surivival Of End Stage Colorectal Cancer Patients

  8/5/2015

• Etubics Adds Caskey, Paessler, Zeldis To Leadership Boards

  7/20/2015

• Gerald L. Messerschmidt Joins Etubics As Chief Medical Officer

  7/10/2015

• Etubics Will Present Results Of Its Colorectal Cancer Phase 1 And 2 Immunotherapy Trial At The Annual American Society of Clinical Oncology Meeting In Chicago

  5/29/2014

• Etubics Awarded $1.5 Million Manufacturing Contract for Breast Cancer Immunotherapeutic

  9/27/2013

• Etubics Platform Generates Solid Immune Response in Colorectal Cancer Patients

  5/7/2013

• Etubics Platform Generates Solid Immune Response in Colorectal Cancer Patients

  5/6/2013

• Etubics Platform Generates Solid Immune Response in Colorectal Cancer Patients

  5/6/2013

• Etubics to Present at Biotech Showcase 2013

  1/4/2013

• Gilbert S. Omenn Joins Etubics Board of Directors

  12/20/2012

• Etubics Platform Controls HIV and H1N1 Infection in Animal Model

  12/18/2012

• Etubics Awarded Grant for Therapeutic Colon Cancer Vaccine Program

  11/3/2010

• Etubics Presents "Next Generation" Of Adenovirus Vaccine At Annual Aids Vaccine Conference

  9/27/2010

• Etubics Enters Phase I Cancer Clinical Trials Focused On Colorectal Cancer

  7/28/2010

• Etubics Awarded Grant from the National Institutes of Health (NIH) for Continued Development of HIV Vaccine

  8/23/2007

• Etubics Reports Breakthrough Next Generation HIV Vaccine at AIDS Conference

  8/21/2007